✦ LIBER ✦

CMV antigenemia following bone marrow transplantation: Risk factors and outcomes

✍ Scribed by Raymond U. Osarogiagbon; Todd E. Defor; Michael A. Weisdorf; Alejo Erice; Daniel J. Weisdorf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical utility of CMV surveillance

✍ Humar, A; O’Rourke, K; Lipton, J; Messner, H; Meharchand, J; Mahony, J; Walker, 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB

Risk factors for viral reactivation foll

✍ D. Pillay; A. Webster; H. G. Prentice; P. D. Griffiths 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 385 KB

Lack of reactivity to CMV pp65 antigenem

✍ Seropian, S; Ferguson, D; Salloum, E; Cooper, D; Landry, M L 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Outcomes of Renal Transplantation Follow

✍ Khaled Hamawi; Margarida De Magalhaes-Silverman; J. Andrew Bertolatus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Risk factors in interstitial pneumonitis

✍ Jose L. Ping Y Torres; Dean S. Bross; Wing-chef Lam; Moody D. Wharam; George W. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 665 KB

Comparison of cytomegalovirus (CMV) anti

✍ Sakamaki, H; Yuasa, K; Goto, H; Tanikawa, S; Akiyama, H; Onozawa, Y; Okamoto, R; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB